Latest Breaking News On - Liu yutao - Page 1 : comparemela.com

YANTAI, China, June 3, 2024 /PRNewswire/ RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center

United statesFang jianminLiu yutaoAmerican society of clinical oncology annual meetingChinese academy of medical sciences cancer hospitalPrnewswire remegen co ltdRemegen coRemegen co ltdAmerican societyClinical oncology annual meetingProfessor liu yutaoChinese academyMedical sciences cancer hospital